[{"symbol": "BIGT.L", "assetClass": "Equity", "aum": 15895245, "avgVolume": 1279, "cusip": "", "description": "NA", "domicile": "IE", "etfCompany": "L&G", "expenseRatio": 0.49, "inceptionDate": "2018-01-23", "isin": "IE00BF0H7608", "name": "L&G Pharma Breakthrough UCITS ETF", "nav": 8.33, "navCurrency": "GBP", "sectorsList": [{"industry": "Basic Materials", "exposure": 5.89}, {"industry": "Communication Services", "exposure": 0}, {"industry": "Consumer Cyclical", "exposure": 0}, {"industry": "Consumer Defensive", "exposure": 0}, {"industry": "Energy", "exposure": 0}, {"industry": "Financial Services", "exposure": 0}, {"industry": "Healthcare", "exposure": 94.11}, {"industry": "Industrials", "exposure": 0}, {"industry": "Real Estate", "exposure": 0}, {"industry": "Technology", "exposure": 0}, {"industry": "Utilities", "exposure": 0}], "website": "https://fundcentres.landg.com/en/uk/institutional/fund-centre/ETF/Pharma-Breakthrough/", "holdingsCount": 0}]